Wuhan Coronavirus: A global emergency
Despite strict travel guidelines, and restricted movement to and from- China, the caseloads of Wuhan Coronavirus are increasing at an alarming rate, with suspected cases now been confirmed, and a cloud of uncertainty on the number of deaths it may cause, looming. With the infected cases totalling to 45,168, and the deaths around 1,115- surpassing the death rate reported at the time of Severe acute respiratory syndrome (#SARS)- the novel Coronavirus has now come to know as Coronavirus disease 2019 (COVID-19). Therapies, which Pharma companies are reportedly working on, and have the potential to cure the coronavirus epidemic are: Noravax MERS, Invio’s INO-4700, Biocryst’s Galidesivir, AbbVie’s Lopinavir HIV inhibitor, Regeneron’s REGN3048-3051. To read more about coronavirus, visit: https://www.delveinsight.com/blog/coronavirus/ or https://www.delveinsight.com/blog/coronavirus-2019-ncov-is-now-covid-19/